These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 32698129)

  • 61. Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity.
    Martin SD; Connor T; Sanigorski A; McEwen KA; Henstridge DC; Nijagal B; De Souza D; Tull DL; Meikle PJ; Kowalski GM; Bruce CR; Gregorevic P; Febbraio MA; Collier FM; Walder KR; McGee SL
    Cell Death Dis; 2023 Dec; 14(12):787. PubMed ID: 38040704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of CTRP1 disrupts glucose and lipid homeostasis.
    Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of protein kinase D activity demonstrates redundancy in cardiac glucose metabolism and preserves cardiac function in obesity.
    De Jong KA; Hall LG; Renton MC; Connor T; Martin SD; Kowalski GM; Shaw CS; Bruce CR; Howlett KF; McGee SL
    Mol Metab; 2020 Dec; 42():101105. PubMed ID: 33099046
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 66. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protein kinase D (PKD) on the crossroad of lipid absorption, synthesis and utilization.
    Wit M; Belykh A; Sumara G
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119653. PubMed ID: 38104800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reducing hepatic PKD activity lowers circulating VLDL cholesterol.
    Genders AJ; Connor T; Morrison S; Bond ST; Drew BG; Meikle PJ; Howlett KF; McGee SL
    J Endocrinol; 2020 Sep; 246(3):265-276. PubMed ID: 32698129
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of protein kinase D (PKD) in intracellular nutrient sensing and regulation of adaptive responses to the obese environment.
    Renton MC; McGee SL; Howlett KF
    Obes Rev; 2021 Mar; 22(3):e13145. PubMed ID: 32929844
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.